65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79720D0153
- Awardee
-
Xeris Pharmaceuticals, Inc. UEI YAV5AK7VKJ31
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $4,119,200.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
Xeris Pharmaceuticals, Inc. was awarded a multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 on July 15, 2020. This civilian agency contract, with no small business set-aside, carries a ceiling value of $4,119,200 and an ultimate completion date of April 1, 2026. The contract establishes a framework for the VA to procure drugs, pharmaceuticals, and hematology-related products from Xeris to support healthcare operations across the VA's integrated service network. As a small disadvantaged business manufacturer registered in the System for Award Management (SAM.gov), Xeris provides access to specialty pharmaceutical therapies through this multiple-award vehicle, enabling the VA to source products efficiently under pre-negotiated terms and pricing.
Under this parent Federal Supply Schedule contract, the VA National Acquisition Center issued a single-award Blanket Purchase Agreement (BPA) to Xeris Pharmaceuticals valued at $661,240.80, effective June 17, 2022 through March 31, 2026. This BPA specifically covers KEVEYIS, a specialty pharmaceutical used to treat hyperkalemic periodic paralysis in veteran patients. The BPA streamlines procurement operations by establishing predetermined contract terms and pricing for this clinically necessary medication, enabling efficient ordering and consistent supply management. The award to Xeris demonstrates the VA's utilization of tiered procurement mechanisms—including the parent Federal Supply Schedule and targeted BPAs—to ensure reliable access to essential, specialized drug therapies for the veteran population requiring treatment for rare periodic paralysis conditions.
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79722A0022 | National Acquisition Center (VA) | $661,241 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 26
Quick answers
Who was awarded contract 36F79720D0153?
36F79720D0153 was awarded to Xeris Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2020.
How much is contract 36F79720D0153 worth?
36F79720D0153's own ceiling is $4,119,200.
Who can order from contract 36F79720D0153?
36F79720D0153 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79720D0153 part of a contract vehicle?
Yes. 36F79720D0153 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79720D0153 competed?
The extent of competition for 36F79720D0153 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV